Personal information

Emails & domains

Verified email domains

Activities

Collapse all

Employment (4)

TimeTeller® GmbH: Hamburg, DE

2024-10-01 to present | R&D Pharmacokinetic Modelling
Employment
Source: Self-asserted source
Oliver Zimmer

MSH Medical School Hamburg – University of Applied Sciences and Medical University: Hamburg, DE

2024-09-16 to present | Postdoctoral Researcher (ISM Institute for Systems Medicine)
Employment
Source: Self-asserted source
Oliver Zimmer

University of Regensburg: Regensburg, DE

2024-01-21 to 2024-07-31 | Postdoctoral Researcher (Pharmaceutical Technology)
Employment
Source: Self-asserted source
Oliver Zimmer

University of Regensburg: Regensburg, DE

2018-07-16 to 2024-01-21 | PhD student (Department of Pharmaceutical Technology)
Employment
Source: Self-asserted source
Oliver Zimmer

Education and qualifications (2)

Universität Regensburg: Regensburg, DE

2018-07-16 to 2024-01-21 | Dr. rer. nat. (Department of Pharmaceutical Technology)
Education
Source: Self-asserted source
Oliver Zimmer

Universität Hamburg: Hamburg, DE

2012-10 to 2018-06 | Licensure as Pharmacist (Institute of Pharmacy)
Education
Source: Self-asserted source
Oliver Zimmer

Works (6)

The quantity of ligand–receptor interactions between nanoparticles and target cells

Nanoscale Horizons
2025 | Journal article
DOI: 10.1039/D4NH00645C
Contributors: Kathrin Schorr; Sebastian Beck; Oliver Zimmer; Felix Baumann; Max Keller; Ralph Witzgall; Achim Goepferich
Source: check_circle
Crossref

Conditional Cell-Penetrating Peptide Exposure as Selective Nanoparticle Uptake Signal

ACS Applied Materials & Interfaces
2024-07-24 | Journal article
DOI: 10.1021/acsami.4c07821
Part of ISSN: 1944-8244
Part of ISSN: 1944-8252
Contributors: Melanie Walter; Merlin Bresinsky; Oliver Zimmer; Steffen Pockes; Achim Goepferich
Source: Self-asserted source
Oliver Zimmer

On the uncertainty of the correlation between nanoparticle avidity and biodistribution

European Journal of Pharmaceutics and Biopharmaceutics
2024-05 | Journal article
DOI: 10.1016/j.ejpb.2024.114240
Contributors: Oliver Zimmer; Achim Goepferich
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

How clathrin-coated pits control nanoparticle avidity for cells

Nanoscale Horizons
2023 | Journal article
DOI: 10.1039/D2NH00543C
Contributors: Oliver Zimmer; Achim Goepferich
Source: check_circle
Crossref

Impact of interferon-γ on the target cell tropism of nanoparticles

Journal of Controlled Release
2023-10 | Journal article
DOI: 10.1016/j.jconrel.2023.08.034
Part of ISSN: 0168-3659
Contributors: Oliver Zimmer; Melanie Walter; Marius Remmert; Olga Maier; Ralph Witzgall; Achim Goepferich
Source: Self-asserted source
Oliver Zimmer

Airway Delivery of Hydrogel-Encapsulated Niclosamide for the Treatment of Inflammatory Airway Disease

International Journal of Molecular Sciences
2022-01-19 | Journal article
DOI: 10.3390/ijms23031085
Part of ISSN: 1422-0067
Contributors: Jiraporn Ousingsawat; Raquel Centeio; Inês Cabrita; Khaoula Talbi; Oliver Zimmer; Moritz Graf; Achim Göpferich; Rainer Schreiber; Karl Kunzelmann
Source: Self-asserted source
Oliver Zimmer
How many people are using ORCID?